MANCHESTER, Conn., Dec. 20, 2010 (GLOBE NEWSWIRE) -- Charter Medical, a subsidiary of Lydall, Inc. (NYSE:LDL) announced today that it has received 510(k) clearance on its next generation Cell Freeze ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback